NASDAQ:ATHA
Athira Pharma, Inc. Stock News
$2.71
+0.500 (+22.62%)
At Close: May 16, 2024
BOTHELL, Wash., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health a
New York, New York--(Newsfile Corp. - August 23, 2021) - WHY: New York, N.Y., August 22, 2021. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athira Pharma,
LOS ANGELES--(BUSINESS WIRE)---- $ATHA #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athira Pharma, Inc. (ATHA)
Athira Class Action Reminder
08:27am, Sunday, 22'nd Aug 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
FINAL NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit - ATHA
09:03am, Saturday, 21'st Aug 2021
SAN DIEGO, Aug. 21, 2021 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Athira Pharma, Inc. (NASDAQ: ATHA) securities between September 18, 2020 and June 17, 2021, inclu
LOS ANGELES, Aug. 20, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired
Los Angeles, California--(Newsfile Corp. - August 20, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma,
New Orleans, Louisiana--(Newsfile Corp. - August 19, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA
09:45pm, Thursday, 19'th Aug 2021
NEW YORK, Aug. 19, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of. Athira Pharma, Inc. ("Athira" or the "Company") (NASDAQ: ATHA).
Athira Shareholder Alert
06:03pm, Thursday, 19'th Aug 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
Los Angeles, California--(Newsfile Corp. - August 19, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma,
BENSALEM, Pa. – , Aug. 18, 2021 /PRNewswire/ -- Law Offices of Howard G.
TUESDAY DEADLINE: Investors with Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit – ATHA
10:53pm, Wednesday, 18'th Aug 2021
SAN DIEGO--(BUSINESS WIRE)-- #ATHAstock--The suit alleges defendants issued false statements concerning Athira business and prospects, resulting in its stock trading at inflated prices.
Radnor, Pennsylvania--(Newsfile Corp. - August 17, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds Athira Pharma, Inc. (NASDAQ: ATHA) ("Athira") investors that securities fraud cl
LOS ANGELES--(BUSINESS WIRE)---- $ATHA #ATHA--SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc.
